← All stocks

Core Scientific, Inc./tx

CORZ Net buying
CIK 0001839341 #1249 in the set updated 21 Sep 2026
Bought (1 mo)
$97.98K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$694.93K
$694.93K on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 4 sales
Net
−$596.95K
+$97.98K against sales at will

By person

13 insiders · 5 transactions
88.8×

Adam Sullivan holds 88.8 times base salary in stock. $72.45M of shares against $815.77K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam Sullivan last reported holding, valued at $16.33, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DUCHENE TODD M
See remarks
$694.93K (4) scheduled
−$694.93K
1,907,896
0.5937%
$31.16M
+12.6%
Weiss Eric Stanton
Director
$97.98K (1)
+$97.98K
265,262
0.0825%
$4.33M
+35.9%
Sullivan Adam Taylor
Chief Executive Officer
4,436,426
1.38%
$72.45M
+9.1%
Nygaard James P Jr
EVP, Chief Financial Officer
1,043,056
0.3246%
$17.03M
+432.1%
Rozov Yadin
Director
454,162
0.1413%
$7.42M
+77.9%
Sterling Denise Marie Brucia
Chief Financial Officer
440,028
0.1369%
$7.19M
−0.2%
Levy Jordan
Director
325,462
0.1013%
$5.31M
+45.3%
Patten Jarrod M
Director
320,448
0.0997%
$5.23M
+6.8%
Booth Jeffrey David
Director
214,262
0.0667%
$3.50M
+22.3%
Becker Todd A
Director
195,687
0.0609%
$3.20M
−36.8%
CRAIN ELIZABETH
Director
71,348
0.0222%
$1.17M
Adams Mark
Director
27,594
0.0086%
$450.61K
Smith Stephen M
Director
18,961
0.0059%
$309.63K
Insider
Date
Role
Action
Shares
Price
Amount
Weiss Eric Stanton
15 Sep 2026
Director
Buy
6,000
$16.33
$97.98K
DUCHENE TODD M
14 Sep 2026
See remarks
Sold on a plan
10,000
$17.14
$171.36K
DUCHENE TODD M
8 Sep 2026
See remarks
Sold on a plan
10,000
$18.67
$186.74K
DUCHENE TODD M
31 Aug 2026
See remarks
Sold on a plan
10,000
$16.23
$162.34K
DUCHENE TODD M
24 Aug 2026
See remarks
Sold on a plan
10,000
$17.45
$174.49K

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 1 Jun 2022